Corticosteroid-Sparing Effects of Immunoglobulin in Myasthenia Gravis
Dr. Gordon Smith talks with Dr. Vera Bril about exploring the potential use of immunoglobulin as a corticosteroid-sparing agent in patients with Myasthenia Gravis.
Read the related article in Neurology®.
Disclosures can be found at Neurology.org.
You May Also Like
Brian's Run Pod
Brian Patterson
Lifestyle of Longevity
Dr. Kati Ernst & Kristine Zeller
Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio
BlackBox - Verstehen, was im Kopf passiert
Psychologinnen Maxi Diers und Barbara Focke
HerbRally
Mason Hutchison
Voices for Voices®
Founder of Voices for Voices®, Justin Alan Hayes
Johannes Hansen Podcast
Johannes Hansen
The Good Glow
The Good Glow Productions
Podcasts Archives - Extreme Health Radio
Justin Stellman
Daily Motivations
Tolulope Akodu
Brian's Run Pod
Brian Patterson
Lifestyle of Longevity
Dr. Kati Ernst & Kristine Zeller
Be Calm and Relaxed with Rain and Thunder for Sleeping
ColoredJuice Podcast Studio
BlackBox - Verstehen, was im Kopf passiert
Psychologinnen Maxi Diers und Barbara Focke
HerbRally
Mason Hutchison
Voices for Voices®
Founder of Voices for Voices®, Justin Alan Hayes
Johannes Hansen Podcast
Johannes Hansen
The Good Glow
The Good Glow Productions
Podcasts Archives - Extreme Health Radio
Justin Stellman
Daily Motivations
Tolulope Akodu
Community discussion